My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Sep 14,2016

Net profit of Future Enterprises rose 615.37% to Rs 315.48 crore in the quarter ended June 2016 as against Rs 44.10 crore during the previous quarter ended June 2015. Sales declined 67.64% to Rs 921.19 crore in the quarter ended June 2016 as against Rs 2846.84 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales921.192846.84-68
OPM %24.969.91-
PBDT295.07184.1360
PBT142.3249.92185
NP315.4844.10615

Powered by Capital Market - Live News

Inventure Growth & Securities reports consolidated net profit of Rs 0.02 crore in the September 2016 quarter
Nov 11,2016

Net profit of Inventure Growth & Securities reported to Rs 0.02 crore in the quarter ended September 2016 as against net loss of Rs 4.68 crore during the previous quarter ended September 2015. Sales rose 7.72% to Rs 5.30 crore in the quarter ended September 2016 as against Rs 4.92 crore during the previous quarter ended September 2015.

ParticularsQuarter Endedn++Sep. 2016Sep. 2015% Var. Sales5.304.92 8 OPM %130.94-82.72 - PBDT7.05-4.22 LP PBT6.81-4.47 LP NP0.02-4.68 LP

Powered by Capital Market - Live News

Apollo Hospitals slides after reporting marginal rise in profitability in Q2
Nov 11,2016

The result was announced during market hours today, 11 November 2016.

Meanwhile, the S&P BSE Sensex was down 723.39 points or 2.63% at 26,794.29.

On BSE, so far 20,000 shares were traded in the counter as against average daily volume of 12,000 shares in the past two weeks. The stock hit a high of Rs 1,315 and a low of Rs 1,261.80 so far during the day. The stock had hit a 52-week low of Rs 1,212 on 9 November 2016. The stock had hit a record high of Rs 1,544 on 2 March 2016.

The large-cap company has equity capital of Rs 69.56 crore. Face value per share is Rs 5.

Apollo Hospitals is one of Asias largest healthcare groups.

Powered by Capital Market - Live News

China Stocks gain to fresh 10-months high
Nov 11,2016

Mainland China stock market closed at fresh 10-months high on Friday, 11 November 2016, on tracking gains in global market, supported by hopes for U.S. policies under U.S. President-elect Donald Trump. All major sectors gained, led by metal producers and construction companies. The benchmark Shanghai Composite Index grew 0.78% to close at 3,196.04 points, taking its advance from its Jan. 28 low to more than 20 percent. The CSI 300 index closed marginal 0.01% down at 3,390.25 points.

Powered by Capital Market - Live News

V I P Industries consolidated net profit rises 4.57% in the September 2016 quarter
Nov 11,2016

Net profit of V I P Industries rose 4.57% to Rs 18.29 crore in the quarter ended September 2016 as against Rs 17.49 crore during the previous quarter ended September 2015. Sales declined 3.32% to Rs 284.88 crore in the quarter ended September 2016 as against Rs 294.67 crore during the previous quarter ended September 2015.

ParticularsQuarter Endedn++Sep. 2016Sep. 2015% Var. Sales284.88294.67 -3 OPM %9.229.31 - PBDT29.1127.37 6 PBT25.8623.84 8 NP18.2917.49 5

Powered by Capital Market - Live News

Nikkei extends gain on softer yen
Nov 11,2016

The Japan share market inclined for second straight session on Friday, 11 November 2016, supported by yen depreciation to mid 106-level against greenback and hopes Trump administration will boost spending and spur U.S. economic growth. 18 out of 33 TSE industry categories closed in positive territory, led by Insurance, Banks, Nonferrous Metals, Securities & Commodities Futures, and Iron & Steel stocks, while Information & Communication, Fishery, Agriculture & Forestry, Retail Trade, and Electric Power & Gas were notable losers. The 225-issue Nikkei Stock Average rose 30.37 points, or 0.18%, to 17,374.79, while the broader Topix index of all First Section issues on the Tokyo Stock Exchange jumped 1.93 points, or 0.14%, to end at 1,378.28.

Powered by Capital Market - Live News

Australia Stocks incline for second straight day
Nov 11,2016

Australian share market inclined for second successive session on Friday, 11 November 2016, on the back positive lead from Wall Street overnight and jump in commodity prices including iron ore. Most sectors on the ASX closed higher, with financial, materials, and energy sectors registering the biggest gains. At the closing bell, the benchmark S&P/ASX 200 index inclined 41.90 points, or 0.79%, to 5,370.70, while the broader All Ordinaries index increased 37.70 points, or 0.7%, to 5,446.60.

Powered by Capital Market - Live News

G V Films to announce September quarter results
Nov 11,2016

G V Films announced that a meeting of the Board of Directors of the Company is scheduled to be held on 14 November 2016, inter alia, to transact the following;

- To consider and approve the Unaudited Financial Results of the Company for quarter ended 30 September 2016.

Powered by Capital Market - Live News

G V Films to announce September quarter results
Nov 11,2016

G V Films announced that a meeting of the Board of Directors of the Company is scheduled to be held on 14 November 2016, inter alia, to transact the following;

- To consider and approve the Unaudited Financial Results of the Company for quarter ended 30 September 2016.

Powered by Capital Market - Live News

Ipca Laboratories nudges up after posting stellar Q2 results
Nov 11,2016

The result was announced during market hours today, 11 November 2016.

Meanwhile, the S&P BSE Sensex was down 632.94 points or 2.3% at 26,884.74.

High volumes were witnessed on the counter. On BSE, so far 1.05 lakh shares were traded in the counter as against average daily volume of 34,209 shares in the past one quarter. The stock hit a high of Rs 618 and low of Rs 575 so far during the day. The stock had hit a 52-week high of Rs 888 on 19 August 2015. The stock had hit a 52-week low of Rs 402 on 6 June 2016. The stock underperformed the market over the past one month till 10 November 2016, declining 4.47% compared with 2.01% fall in the Sensex. The scrip however outperformed the market in past one quarter, gaining 17.96% as against Sensexs 0.93% fall.

The mid-cap company has equity capital of Rs 25.24 crore. Face value per share is Rs 2.

Ipca Laboratories earnings before interest, tax, depreciation and amortization (EBITDA) margin rose to 14.68% in Q2 September 2016 from 11.25% in Q2 September 2015. The companys Indian formulations income rose 23% to Rs 404.36 crore in Q2 September 2016 over Q2 September 2015. Exports income rose 10% to Rs 410.34 crore in Q2 September 2016 over Q2 September 2015.

Ipca Laboratories is vertically integrated and produces finished dosage forms and active pharmaceuticals ingredients.

Powered by Capital Market - Live News

Board of Noida Medicare Centre to consider September quarter results
Nov 11,2016

Noida Medicare Centre announced that the Board Meeting of the Company will be held on 14 November 2016, to consider and take on record Unaudited Financial Results for the quarter and six months ended on 30 September 2016.

Powered by Capital Market - Live News

Repro India appoints director
Nov 11,2016

Repro India announced that the Board of Directors of the Company in their meeting held on 11 November 2016, have appointed Ms. Bhumika Batra as an Additional Director (Non-Executive Independent Director) on the Board of the Company w.e.f. 11 November 2016.

Powered by Capital Market - Live News

Infosys announces investment in TidalScale
Nov 11,2016

Infosys announced that it has made an investment in TidalScale,a pioneer in Software-Defined Servers that simplify the way companies can apply computing resources to tackle big problems. The investment will be completed on or before 24 November 2016.

Powered by Capital Market - Live News

Board of Mahindra & Mahindra approves change in directorate
Nov 11,2016

Mahindra & Mahindra announced that the recommendation of the Governance, Nomination and Remuneration Committee, the Board of Directors of the Company at its Meeting held on 11 November 2016, has

1. Designated and appointed Anand Mahindra, who currently holds the position of Chairman and Managing Director, as Executive Chairman for a period of 5 (Five) years with effect from12 November 2016 upto and including 11 November 2021; subject to approval of the Shareholders;and

2. Appointed Pawan Goenka who currently holds the position of Executive Director and Group President (Auto and Farm Sector), as Managing Director for a period of 4 (Four) years from 12 November 2016 upto and including 11 November 2020; subject to approval of the Shareholders.

Powered by Capital Market - Live News

Mahindra & Mahindra appoints director
Nov 11,2016

Mahindra & Mahindra announced that the Board of Directors of the Company at its Meeting held on 11 November 2016, has approved the appointment of T. N. Manoharan, as an Additional Director of the Company who would be an Independent Director, with effect from 11 November 2016.

Powered by Capital Market - Live News

Alkem Lab declines as bottom line growth lags growth in top line in Q2
Nov 11,2016

The result was announced during market hours today, 11 November 2016.

Meanwhile, the S&P BSE Sensex was down 592.75 points or 2.15% at 26,924.93.

On BSE, so far 12,000 shares were traded in the counter as against average daily volume of 5,704 shares in the past two weeks. The stock hit a high of Rs 1,680 and a low of Rs 1,568.20 so far during the day. The stock had hit a record high of Rs 1,852.95 on 29 September 2016. The stock had hit a record low of Rs 1,175 on 2 May 2016.

The large-cap company has equity capital of Rs 23.91 crore. Face value per share is Rs 2.

The companys earnings before interest, taxation, depreciation and amortization (EBITDA) rose 21.5% to Rs 310.50 crore in Q2 September 2016 over Q2 September 2015. EBITDA margin improved to 18.9% in Q2 September 2016, from 18.5% in Q2 September 2015.

Commenting on the companys performance, Prabhat Agrawal, CEO, Alkem, said the company has delivered a robust growth in its India business largely driven by strong execution of its market strategies. The companys international business too delivered a healthy growth during the quarter mainly driven by its US business, he said. Alkems ongoing efforts towards margin improvement also are yielding results as evident from year on year (YoY) improvement in its gross and EBITDA margins despite the regulatory price cuts, Agrawal said. Alkem looks forward to build on this momentum, he added.

Alkem Laboratories is a pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.

Powered by Capital Market - Live News